The cost of long‐term follow‐up of high‐risk infants for research studies

By  

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 10, 2015-10 ,pp. : 1012-1016

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors for cisplatin‐induced long‐term nephrotoxicity in pediatric cancer survivors

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 3, 2015-06 ,pp. : 406-413

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of pathologic staging on the long‐term oncologic outcomes of patients with clinically high‐risk prostate cancer

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1656-1662

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation

By  

Urologia Internationalis, Vol. 84, Iss. 2, 2010-03 ,pp. : 164-173

Karger

Access to resources Recommend Favorite

Long-Term Efficiency and Toxicity of Adjuvant Dose-Dense Sequential Adriamycin-Paclitaxel-Cyclophosphamide Chemotherapy in High-Risk Breast Cancer

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 271-273

Karger

Access to resources Recommend Favorite